Breaking News

Althea Launches ADC and Cytotoxic Service Offerings

Can accommodate projects from early clinical phase through commercial launch and supply

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Ajinomoto Althea, Inc. is expanding its biologic drug product manufacturing operations to include highly active materials such as Antibody Drug Conjugates (ADCs). The new facility is located near Althea’s existing operations in San Diego, CA. Process and analytical development labs will be available for client programs in January 2016. The labs provide services to support early stage ADC product development efforts and are equipped to perform bioconjugation, process development and optimizati...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters